HomeCompareEKG vs NOBL

EKG vs NOBL: Dividend Comparison 2026

EKG yields 12.38% · NOBL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKG wins by $17.2K in total portfolio value
10 years
EKG
EKG
● Live price
12.38%
Share price
$16.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.2K
Annual income
$2,676.51
Full EKG calculator →
NOBL
NOBL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NOBL calculator →

Portfolio growth — EKG vs NOBL

📍 EKG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKGNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKG + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKG pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKG
Annual income on $10K today (after 15% tax)
$1,051.98/yr
After 10yr DRIP, annual income (after tax)
$2,275.03/yr
NOBL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, EKG beats the other by $1,510.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKG + NOBL for your $10,000?

EKG: 50%NOBL: 50%
100% NOBL50/50100% EKG
Portfolio after 10yr
$36.6K
Annual income
$1,787.86/yr
Blended yield
4.88%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKG buys
0
NOBL buys
0
No recent congressional trades found for EKG or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKGNOBL
Forward yield12.38%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$45.2K$28.0K
Annual income after 10y$2,676.51$899.19
Total dividends collected$19.4K$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EKG vs NOBL ($10,000, DRIP)

YearEKG PortfolioEKG Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,938$1,237.62$11,120$420.00+$818.00EKG
2$14,154$1,380.77$12,357$458.31+$1.8KEKG
3$16,675$1,530.03$13,721$499.76+$3.0KEKG
4$19,527$1,684.61$15,227$544.58+$4.3KEKG
5$22,737$1,843.67$16,885$593.02+$5.9KEKG
6$26,335$2,006.35$18,713$645.34+$7.6KEKG
7$30,350$2,171.81$20,724$701.81+$9.6KEKG
8$34,814$2,339.20$22,938$762.73+$11.9KEKG
9$39,759$2,507.70$25,372$828.41+$14.4KEKG
10$45,219$2,676.51$28,047$899.19+$17.2KEKG

EKG vs NOBL: Complete Analysis 2026

EKGStock

The First Trust Nasdaq Lux Digital Health Solutions ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the Nasdaq Lux Health Tech Index (the "Index"). The Fund will normally invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the Index.

Full EKG Calculator →

NOBLETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →
📬

Get this EKG vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKG vs SCHDEKG vs JEPIEKG vs OEKG vs KOEKG vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.